purchase customization

1 Study Coverage
1.1 Subcutaneous Drug Delivery Devices Product Introduction
1.2 Market by Type
1.2.1 Global Subcutaneous Drug Delivery Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prefilled Injectable
1.2.3 Filled Injectable
1.3 Market by Application
1.3.1 Global Subcutaneous Drug Delivery Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Subcutaneous Drug Delivery Devices Sales Estimates and Forecasts 2017-2028
2.2 Global Subcutaneous Drug Delivery Devices Revenue Estimates and Forecasts 2017-2028
2.3 Global Subcutaneous Drug Delivery Devices Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Subcutaneous Drug Delivery Devices Sales by Region
2.4.1 Global Subcutaneous Drug Delivery Devices Sales by Region (2017-2022)
2.4.2 Global Sales Subcutaneous Drug Delivery Devices by Region (2023-2028)
2.5 Global Subcutaneous Drug Delivery Devices Revenue by Region
2.5.1 Global Subcutaneous Drug Delivery Devices Revenue by Region (2017-2022)
2.5.2 Global Subcutaneous Drug Delivery Devices Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Subcutaneous Drug Delivery Devices Sales by Manufacturers
3.1.1 Global Top Subcutaneous Drug Delivery Devices Manufacturers by Sales (2017-2022)
3.1.2 Global Subcutaneous Drug Delivery Devices Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Subcutaneous Drug Delivery Devices in 2021
3.2 Global Subcutaneous Drug Delivery Devices Revenue by Manufacturers
3.2.1 Global Subcutaneous Drug Delivery Devices Revenue by Manufacturers (2017-2022)
3.2.2 Global Subcutaneous Drug Delivery Devices Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Subcutaneous Drug Delivery Devices Revenue in 2021
3.3 Global Subcutaneous Drug Delivery Devices Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Subcutaneous Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Subcutaneous Drug Delivery Devices Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Subcutaneous Drug Delivery Devices Sales by Type
4.1.1 Global Subcutaneous Drug Delivery Devices Historical Sales by Type (2017-2022)
4.1.2 Global Subcutaneous Drug Delivery Devices Forecasted Sales by Type (2023-2028)
4.1.3 Global Subcutaneous Drug Delivery Devices Sales Market Share by Type (2017-2028)
4.2 Global Subcutaneous Drug Delivery Devices Revenue by Type
4.2.1 Global Subcutaneous Drug Delivery Devices Historical Revenue by Type (2017-2022)
4.2.2 Global Subcutaneous Drug Delivery Devices Forecasted Revenue by Type (2023-2028)
4.2.3 Global Subcutaneous Drug Delivery Devices Revenue Market Share by Type (2017-2028)
4.3 Global Subcutaneous Drug Delivery Devices Price by Type
4.3.1 Global Subcutaneous Drug Delivery Devices Price by Type (2017-2022)
4.3.2 Global Subcutaneous Drug Delivery Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Subcutaneous Drug Delivery Devices Sales by Application
5.1.1 Global Subcutaneous Drug Delivery Devices Historical Sales by Application (2017-2022)
5.1.2 Global Subcutaneous Drug Delivery Devices Forecasted Sales by Application (2023-2028)
5.1.3 Global Subcutaneous Drug Delivery Devices Sales Market Share by Application (2017-2028)
5.2 Global Subcutaneous Drug Delivery Devices Revenue by Application
5.2.1 Global Subcutaneous Drug Delivery Devices Historical Revenue by Application (2017-2022)
5.2.2 Global Subcutaneous Drug Delivery Devices Forecasted Revenue by Application (2023-2028)
5.2.3 Global Subcutaneous Drug Delivery Devices Revenue Market Share by Application (2017-2028)
5.3 Global Subcutaneous Drug Delivery Devices Price by Application
5.3.1 Global Subcutaneous Drug Delivery Devices Price by Application (2017-2022)
5.3.2 Global Subcutaneous Drug Delivery Devices Price Forecast by Application (2023-2028)
6 North America
6.1 North America Subcutaneous Drug Delivery Devices Market Size by Type
6.1.1 North America Subcutaneous Drug Delivery Devices Sales by Type (2017-2028)
6.1.2 North America Subcutaneous Drug Delivery Devices Revenue by Type (2017-2028)
6.2 North America Subcutaneous Drug Delivery Devices Market Size by Application
6.2.1 North America Subcutaneous Drug Delivery Devices Sales by Application (2017-2028)
6.2.2 North America Subcutaneous Drug Delivery Devices Revenue by Application (2017-2028)
6.3 North America Subcutaneous Drug Delivery Devices Market Size by Country
6.3.1 North America Subcutaneous Drug Delivery Devices Sales by Country (2017-2028)
6.3.2 North America Subcutaneous Drug Delivery Devices Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Subcutaneous Drug Delivery Devices Market Size by Type
7.1.1 Europe Subcutaneous Drug Delivery Devices Sales by Type (2017-2028)
7.1.2 Europe Subcutaneous Drug Delivery Devices Revenue by Type (2017-2028)
7.2 Europe Subcutaneous Drug Delivery Devices Market Size by Application
7.2.1 Europe Subcutaneous Drug Delivery Devices Sales by Application (2017-2028)
7.2.2 Europe Subcutaneous Drug Delivery Devices Revenue by Application (2017-2028)
7.3 Europe Subcutaneous Drug Delivery Devices Market Size by Country
7.3.1 Europe Subcutaneous Drug Delivery Devices Sales by Country (2017-2028)
7.3.2 Europe Subcutaneous Drug Delivery Devices Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Subcutaneous Drug Delivery Devices Market Size by Type
8.1.1 Asia Pacific Subcutaneous Drug Delivery Devices Sales by Type (2017-2028)
8.1.2 Asia Pacific Subcutaneous Drug Delivery Devices Revenue by Type (2017-2028)
8.2 Asia Pacific Subcutaneous Drug Delivery Devices Market Size by Application
8.2.1 Asia Pacific Subcutaneous Drug Delivery Devices Sales by Application (2017-2028)
8.2.2 Asia Pacific Subcutaneous Drug Delivery Devices Revenue by Application (2017-2028)
8.3 Asia Pacific Subcutaneous Drug Delivery Devices Market Size by Region
8.3.1 Asia Pacific Subcutaneous Drug Delivery Devices Sales by Region (2017-2028)
8.3.2 Asia Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Subcutaneous Drug Delivery Devices Market Size by Type
9.1.1 Latin America Subcutaneous Drug Delivery Devices Sales by Type (2017-2028)
9.1.2 Latin America Subcutaneous Drug Delivery Devices Revenue by Type (2017-2028)
9.2 Latin America Subcutaneous Drug Delivery Devices Market Size by Application
9.2.1 Latin America Subcutaneous Drug Delivery Devices Sales by Application (2017-2028)
9.2.2 Latin America Subcutaneous Drug Delivery Devices Revenue by Application (2017-2028)
9.3 Latin America Subcutaneous Drug Delivery Devices Market Size by Country
9.3.1 Latin America Subcutaneous Drug Delivery Devices Sales by Country (2017-2028)
9.3.2 Latin America Subcutaneous Drug Delivery Devices Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Subcutaneous Drug Delivery Devices Market Size by Type
10.1.1 Middle East and Africa Subcutaneous Drug Delivery Devices Sales by Type (2017-2028)
10.1.2 Middle East and Africa Subcutaneous Drug Delivery Devices Revenue by Type (2017-2028)
10.2 Middle East and Africa Subcutaneous Drug Delivery Devices Market Size by Application
10.2.1 Middle East and Africa Subcutaneous Drug Delivery Devices Sales by Application (2017-2028)
10.2.2 Middle East and Africa Subcutaneous Drug Delivery Devices Revenue by Application (2017-2028)
10.3 Middle East and Africa Subcutaneous Drug Delivery Devices Market Size by Country
10.3.1 Middle East and Africa Subcutaneous Drug Delivery Devices Sales by Country (2017-2028)
10.3.2 Middle East and Africa Subcutaneous Drug Delivery Devices Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 BD
11.1.1 BD Corporation Information
11.1.2 BD Overview
11.1.3 BD Subcutaneous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 BD Subcutaneous Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BD Recent Developments
11.2 Insulet Corporation
11.2.1 Insulet Corporation Corporation Information
11.2.2 Insulet Corporation Overview
11.2.3 Insulet Corporation Subcutaneous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Insulet Corporation Subcutaneous Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Insulet Corporation Recent Developments
11.3 Enable Injections
11.3.1 Enable Injections Corporation Information
11.3.2 Enable Injections Overview
11.3.3 Enable Injections Subcutaneous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Enable Injections Subcutaneous Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Enable Injections Recent Developments
11.4 West Pharmaceutical Services, Inc
11.4.1 West Pharmaceutical Services, Inc Corporation Information
11.4.2 West Pharmaceutical Services, Inc Overview
11.4.3 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 West Pharmaceutical Services, Inc Recent Developments
11.5 Ypsomed AG
11.5.1 Ypsomed AG Corporation Information
11.5.2 Ypsomed AG Overview
11.5.3 Ypsomed AG Subcutaneous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Ypsomed AG Subcutaneous Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ypsomed AG Recent Developments
11.6 Elcam Medical
11.6.1 Elcam Medical Corporation Information
11.6.2 Elcam Medical Overview
11.6.3 Elcam Medical Subcutaneous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Elcam Medical Subcutaneous Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Elcam Medical Recent Developments
11.7 Amgen
11.7.1 Amgen Corporation Information
11.7.2 Amgen Overview
11.7.3 Amgen Subcutaneous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Amgen Subcutaneous Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Amgen Recent Developments
11.8 Wilhelm Haselmeier
11.8.1 Wilhelm Haselmeier Corporation Information
11.8.2 Wilhelm Haselmeier Overview
11.8.3 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wilhelm Haselmeier Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Subcutaneous Drug Delivery Devices Industry Chain Analysis
12.2 Subcutaneous Drug Delivery Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Subcutaneous Drug Delivery Devices Production Mode & Process
12.4 Subcutaneous Drug Delivery Devices Sales and Marketing
12.4.1 Subcutaneous Drug Delivery Devices Sales Channels
12.4.2 Subcutaneous Drug Delivery Devices Distributors
12.5 Subcutaneous Drug Delivery Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Subcutaneous Drug Delivery Devices Industry Trends
13.2 Subcutaneous Drug Delivery Devices Market Drivers
13.3 Subcutaneous Drug Delivery Devices Market Challenges
13.4 Subcutaneous Drug Delivery Devices Market Restraints
14 Key Findings in The Global Subcutaneous Drug Delivery Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer